| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
CisplatinLung (Neoplasm)| 1 | 1979 | Cis-platinum: a new anticancer agent. | 
| + | - | nl | Br Med J 1(6179):1689-91 (1979) |
| 2 | 1993 | Review of platinum anticancer compounds. | 
| + | - | nl | J Med 24(4-5):209-65 (1993) |
| 3 | 2008 | Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism. | 
| + | - | nl | Met Based Drugs 2008(-):417897 (2008) |
| 4 | 2009 | Cisplatin ototoxicity and protection: clinical and experimental studies. | 
| + | - | nl | Tohoku J Exp Med 219(3):177-86 (2009) |
| 5 | 2003 | Cisplatin and platinum drugs at the molecular level. (Review). | 
| + | - | nl | Oncol Rep 10(6):1663-82 (2003) |
| 6 | 1993 | Cellular accumulation of the anticancer agent cisplatin: a review. | 
| + | - | nl | Br J Cancer 67(6):1171-6 (1993) |
| 7 | 1992 | Modulation of cis-diamminedichloroplatinum(II) resistance: a review. | 
| + | - | nl | Br J Cancer 66(2):227-38 (1992) |
| 8 | 2009 | Inhibition of transcription by platinum antitumor compounds. | 
| + | - | nl | Metallomics 1(4):280-91 (2009) |
| 9 | 1994 | Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. | 
| + | - | nl | J Biol Chem 269(2):787-90 (1994) |
| 10 | 1993 | Platinum resistance: laboratory findings and clinical implications. | 
| + | - | nl | Stem Cells 11(3):182-93 (1993) |
| 11 | 2007 | Cisplatin nephropathy: is cytotoxicity avoidable? | 
| + | - | nl | Nephrol Dial Transplant 22(8):2112-6 (2007) Razzaque MS |
| 12 | 1997 | Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. | 
| + | - | nl | Nephrol Dial Transplant 12(12):2478-80 (1997) |
| 13 | 2003 | New clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. | 
| + | - | nl | Proc Natl Acad Sci U S A 100(7):3611-6 (2003) |
| 14 | 2003 | Nucleotide excision repair pathways involved in Cisplatin resistance in non-small-cell lung cancer. | 
| + | - | nl | Cancer Control 10(4):297-305 (2003) |